These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21131761)

  • 21. The clinical significance of elevated levels of serum CA 19-9.
    Pavai S; Yap SF
    Med J Malaysia; 2003 Dec; 58(5):667-72. PubMed ID: 15190651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum fucosyl transferase activity and serum fucose levels as diagnostic tools in malignancy.
    Sen U; Guha S; Chowdhury JR
    Acta Med Okayama; 1983 Dec; 37(6):457-62. PubMed ID: 6666675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory markers of melanoma progression].
    Bánfalvi T; Edesné MB; Gergye M; Udvarhelyi N; Orosz Z; Gilde K; Kremmer T; Ottó S; Tímár J
    Magy Onkol; 2003; 47(1):89-104. PubMed ID: 12704461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
    Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
    Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum fucose in the diagnosis of malignancy, and its relative merits.
    Deyasi SK; Aikat BK; Sengupta U
    Indian J Pathol Bacteriol; 1975 Jan; 18(1):16-20. PubMed ID: 1132892
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating tumor markers in breast cancer (review).
    Jotti GS; Bombardieri E
    Anticancer Res; 1990; 10(1):253-8. PubMed ID: 2185687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.
    Enjoji M; Nakashima M; Yamaguchi K; Kotoh K; Nakamuta M
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1143-8. PubMed ID: 16048560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum fucose levels in gynaecological disorders including carcinoma cervix.
    Bandlish U; Prabhakar BR; Virmani U
    J Indian Med Assoc; 1991 Sep; 89(9):250-1. PubMed ID: 1795106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
    Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
    Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumour markers in malignant diseases].
    Ottó S; Ferencz A
    Magy Onkol; 2004; 48(1):13-20. PubMed ID: 15105891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis.
    Pavićević R; Bubanović G; Franjević A; Stancić-Rokotov D; Samarzija M
    Coll Antropol; 2008 Jun; 32(2):485-98. PubMed ID: 18756899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the behavior of fucose, sialic acid and mucoproteins in patients with malignant neoplasms before and after roentgen therapy].
    Guerrina G; Traverso G
    Pathologica; 1970; 62(907):75-8. PubMed ID: 5523517
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma.
    Abraha HD; Fuller LC; Du Vivier AW; Higgins EM; Sherwood RA
    Br J Dermatol; 1997 Sep; 137(3):381-5. PubMed ID: 9349333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum pseudocholinesterase activity & protein bound fucose level in oral malignancy.
    Sen R; Sur R; Dasgupta R; Mazumder GC
    Indian J Cancer; 1987 Dec; 24(4):242-50. PubMed ID: 3505513
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of serum levels of magnesium in the patients with malignant tumors].
    Varazashvili Varazi LM; Osmanova VR; Barkadze KI
    Georgian Med News; 2006 Jul; (136):35-9. PubMed ID: 16905841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. REporting recommendations for tumor MARKer prognostic studies (REMARK).
    McShane LM; Altman DG; Sauerbrei W; Taube SE; Gion M; Clark GM;
    Breast Cancer Res Treat; 2006 Nov; 100(2):229-35. PubMed ID: 16932852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reporting recommendations for tumor marker prognostic studies (remark).
    McShane LM; Altman DG; Sauerbrei W; Taube SE; Gion M; Clark GM;
    Exp Oncol; 2006 Jun; 28(2):99-105. PubMed ID: 16837898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic importance of thymidine kinase in colorectal and breast cancer.
    Svobodova S; Topolcan O; Holubec L; Treska V; Sutnar A; Rupert K; Kormunda S; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1907-9. PubMed ID: 17649793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.